Zhang Yuhui, expert from the Health Development Research Center of the National Health Commission: Pay attention to the management of dyslipidemia, optimize the health financing and prevention and control of cardiovascular and cerebrovascular diseases
In the past 30 years, cardiovascular and cerebrovascular diseases have become a major health problem in our country, and the incidence has continued to rise. With the aging of the population and the intensification of unhealthy lifestyles, the burden of disease will continue to increase in the future, becoming one of the most important obstacles to the construction of a healthy China. It is urgent to strengthen the prevention and treatment of cardiovascular and cerebrovascular diseases. The analysis of disease treatment cost trends and coping strategies will provide decision-making support and basis for better prevention and control.
"In the current medical expenditures of Chinese residents, the treatment of cardiovascular and cerebrovascular diseases accounts for the highest proportion." Deputy Director Zhang Yuhui from the National Health Development Research Center (hereinafter referred to as the "center") of the National Health Commission concluded that Chinese residents have cardiovascular and cerebrovascular diseases Medical expenses show the characteristics of large scale, high proportion and rapid growth. According to the latest calculation results of cardiovascular and cerebrovascular diseases carried out by the center, in recent years, the treatment costs for cardiovascular and cerebrovascular diseases in my country have increased at an average annual rate of nearly 10%. By 2018, the overall scale has approached 600 billion yuan, accounting for 17% of the total treatment costs. %, surpassing respiratory diseases, tumors and other diseases, ranking first among all diseases.
"If effective measures are not taken to reverse the current rapid increase in costs, it is estimated that by 2030, the cost of treatment for cardiovascular and cerebrovascular diseases in China may reach 2.9 trillion yuan, accounting for 33% of all medical expenses, and will consume about 30% of the total. Medical insurance funds. So looking into the future, the situation of prevention and control of the cost of this disease is very severe.” Zhang Yuhui further explained that the elderly population is a high risk group of cardiovascular and cerebrovascular diseases. The treatment costs of cardiovascular and cerebrovascular diseases account for 54% of the elderly over the age of.
From the perspective of subdivisions, the cost of atherosclerotic cardiovascular and cerebrovascular diseases accounts for nearly 30% of the cost of cardiovascular and cerebrovascular diseases, and is the top priority of disease prevention and control. "Atherosclerotic cardiovascular and cerebrovascular diseases are directly related to blood lipid levels," said Zhang Yuhui. "Effective control of blood lipids is the key to the prevention of cardiovascular and cerebrovascular diseases, which can greatly reduce the prevalence."
However, the level of national awareness and importance of blood lipid management still needs to be improved. Zhang Yuhui cites a set of data to illustrate this problem intuitively. “Surveys show that 40% of people with dyslipidemia in people over 18 years old in my country, but the 2010 National Chronic Kidney Disease Survey (CNSCKD) project found that the blood lipids of this age group The abnormality awareness rate is only 31.0%, and the treatment rate is only 19.5%. "If blood lipids can be effectively reduced to a clinically reasonable level, subsequent treatment costs for cardiovascular and cerebrovascular diseases can be saved. The health economic analysis carried out by the center shows that if dyslipidemia, a major risk factor for cardiovascular and cerebrovascular diseases, is effectively controlled, it can save more than 370 billion yuan in subsequent serious disease costs by 2030 and save more than 100 billion yuan in medical insurance funds.
"In the process of achieving healthy aging, reducing the burden of cardiovascular and cerebrovascular diseases and medical expenses of the elderly is a problem that our country is working hard to solve, and it is an important part of the strategy to achieve a healthy China." Zhang Yuhui said, "To reduce the burden, from Fundamentally, let patients get less sickness and spend less money. To get less sickness requires health education and mobilization of diseases to maintain the health of the elderly, reduce the severity of illness or disease, and reduce costs. If you spend less money, you must consider passing The medical security system allows the people to reduce their financial burden on medical care, and at the same time, by removing economic barriers, they can obtain more effective and affordable treatment drugs."
Zhang Yuhui concluded: “We need to think about how to take into account the characteristics of cardiovascular and cerebrovascular diseases, give full play to the policy functions of medical insurance and other aspects, and implement targeted reimbursement policies through incentives for medical service behaviors and optimization of health financing. Solve the existing problems such as the excessively high proportion of outpatient out-of-pocket expenses, insufficient utilization of resources in grassroots institutions, and low enthusiasm for prevention and control services, and make patients more willing to strengthen the prevention and treatment of cardiovascular and cerebrovascular diseases, and reduce the overall cost burden."
As an important part of the prevention and control of cardiovascular and cerebrovascular diseases, it is necessary to continuously explore more precise and effective ways to control blood lipids. "In the future, we will establish a high-quality and efficient service system in accordance with national requirements, including the introduction of more high-quality innovative drugs and including them in medical insurance. Directory, to better solve the health problems of the people." Zhang Yuhui said. In the future, it is necessary to explore clearer policies and more effective policy guarantees, and move forward in continuous exploration, and strive to allow the people to enjoy more high-quality and efficient health services.